The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and tolerability of 5-FU, irinotecan (IRI), and nab-paclitaxel (FOLFIRABRAX) with genotype-guided dosing of IRI in previously untreated patients with advanced gastrointestinal (GI) malignancies.
 
Smita Suhas Joshi
No Relationships to Disclose
 
Theodore G. Karrison
No Relationships to Disclose
 
Daniel V.T. Catenacci
Honoraria - Amgen; Bristol-Myers Squibb; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Genmab; Gritstone Bio; Guardant Health; Lilly; Merck; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics
Speakers' Bureau - Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; NantWorks
Research Funding - Genentech; OncoPlex Diagnostics
 
Jaclyn D Peterson
No Relationships to Disclose
 
Mark Zalupski
Research Funding - Halozyme; Newlink Genetics/Pharmatech; Oncomed
 
Brooke Elizabeth Phillips
No Relationships to Disclose
 
Ahad Ali Sadiq
No Relationships to Disclose
 
Amikar Sehdev
Consulting or Advisory Role - Gerson Lehrman Group
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Celgene; Seagen
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Abbvie; Amgen; Gilead Sciences; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Cornerstone Pharmaceuticals; Gilead Sciences; Halozyme
Research Funding - Aduro Biotech; Celgene; FibroGen; Immunomedics; OncoMed
 
Andrea Louise Amico
No Relationships to Disclose
 
Mark Kozloff
Honoraria - Abbvie; Genentech/Roche
Consulting or Advisory Role - Abbvie; Genentech/Roche
Speakers' Bureau - Abbvie; Amgen; Genentech/Roche; Lilly; Merck
 
Blase N. Polite
Consulting or Advisory Role - AstraZeneca; Pfizer
Speakers' Bureau - Bayer/Onyx
Research Funding - Merck
Other Relationship - Gerson Lehrman Group
 
Hedy L. Kindler
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Celgene; Genentech/Roche; GlaxoSmithKline; MedImmune; Merck; Plexxikon; Verastem
Research Funding - AB Science; Aduro Biotech; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Incyte; Lilly; MedImmune; Merck; Verastem
Expert Testimony - Aduro Biotech
 
Manish Sharma
Consulting or Advisory Role - Abbvie; Bayer; Ipsen; Taiho Pharmaceutical